PDF
ePub
Citation
Print
Abstract
Primary Epstein-Barr virus (EBV) infection can manifest with a broad spectrum of neurological complications. There are only rare reports of Guillain-Barré syndrome (GBS) supervening on meningitis in patients with primary EBV infection. Clear evidence of central nervous system in-fection makes it difficult for the clinicians to consider a diagnosis of GBS. We present a patient with GBS supervening on meningitis in primary EBV infection.
Go to : 
References
1. Kleines M, Schiefer J, Stienen A, Blaum M, Ritter K, Häusler M. Expanding the spectrum of neurological disease associated with Ep-stein-Barr virus activity. Eur J Clin Microbiol Infect Dis. 2011; 30:1561–1569.
2. Häusler M, Ramaekers VT, Doenges M, Schweizer K, Ritter K, Schaade L. Neurological complications of acute and persistent Epstein-Barr virus infection in paediatric patients. J Med Virol. 2002; 68:253–263.
3. Kennedy M, Apostolova M. A rare case of infectious mononucleo-sis complicated by Guillain-Barre syndrome. Neurol Int. 2013; 5:20–22.
4. Yuki N, Hartung HP. Guillain–Barré syndrome. N Engl J Med. 2012; 366:2294–2304.
5. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990; 27(Suppl):S21–S24.
6. de Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012; 1:31–43.
7. Portegies P, Corssmit N. Epstein-Barr virus and the nervous system. Curr Opin Neurol. 2000; 13:301–304.
8. Jacobs B, Rothbarth P, van der Meché F, Herbrink P, Schmitz P, de Klerk M, et al. The spectrum of antecedent infections in Guil-lain-Barre syndrome a case-control study. Neurology. 1998; 51:1110–1115.
9. Torre D, Tambini R. Acyclovir for treatment of infectious mononu-cleosis: a metaanalysis. Scand J Infect Dis. 1999; 31:543–547.
10. Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, et al. Acyclovir and prednisolone treatment of acute infectious mono-nucleosis: a multicenter, double-blind, placebocontrolled study. J Infect Dis. 1996; 174:324–331.
Go to :
 | Fig. 1.(A) Leptomeningeal enhancement was found in contrast-enhanced T1-weighted brain magnetic resonance imaging (MRI) with no parenchymal lesion. The findings of T2-weighted brain MRI were unremarkable. (B) No spinal cord lesion was evident in cervical, thoracic, and lumbar spine MRI. |
Table 1.
Epstein-Barr virus serological profiles
| VCA IgM | VCA IgG | EBNA IgG | EBV DNA PCR (serum) | EBV DNA PCR (CSF) | |
|---|---|---|---|---|---|
| On admission | Serum | EBV DNA PCR | Positive | Positive | Positive |
| Three weeks from symptom onset | CSF | Positive | Positive | Negative | Negative |
Table 2.
Electrophysiological findings
XML Download